Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised ‘GISCAD’ trial-Reference-Cited by-同舟云学术

Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised ‘GISCAD’ trial

Published:2011-05 Issue:5 Volume:22 Page:1236-1242
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Labianca R.,Sobrero A.,Isa L.,Cortesi E.,Barni S.,Nicolella D.,Aglietta M.,Lonardi S.,Corsi D.,Turci D.,Beretta G.D.,Fornarini G.,Dapretto E.,Floriani I.,Zaniboni A.

Funder

Italian National Research Council

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/22/5/1236/429702/mdq580.pdf

Reference24 articles.

1. Where do we stand with 5fluorouracil?;Schmoll;Semin Oncol,1999

2. Does biomodulation of 5fluorouracil improve results?;Sobrero;Eur J Cancer,1999

3. Which 5fluorouracil regimen? The great debate;Vincent;Anticancer Drugs,1999

4. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial;Douillard;Lancet,2000

5. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomised GERCOR study;Tournigand;J Clin Oncol,2004

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Do older patients with colorectal cancer experience more deterioration in health-related quality of life than younger patients during the first year of palliative chemotherapy? A prospective real-world observational study;Journal of Geriatric Oncology;2024-04

2. Colorectal Cancer;Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e;2024-01-23

3. Chemotherapy Duration for Various Indications in Colorectal Cancer: a Review;Current Oncology Reports;2023-02-13

4. Heterogeneous disease and intermittent treatment in metastatic colorectal cancer: A case report;Frontiers in Oncology;2023-02-06

5. The epigenetic regulation of cancer cell recovery from therapy exposure and its implications as a novel therapeutic strategy for preventing disease recurrence;Advances in Cancer Research;2023